全文获取类型
收费全文 | 292篇 |
免费 | 31篇 |
专业分类
323篇 |
出版年
2022年 | 3篇 |
2021年 | 4篇 |
2020年 | 4篇 |
2019年 | 9篇 |
2018年 | 13篇 |
2017年 | 4篇 |
2016年 | 8篇 |
2015年 | 7篇 |
2014年 | 10篇 |
2013年 | 20篇 |
2012年 | 13篇 |
2011年 | 16篇 |
2010年 | 11篇 |
2009年 | 15篇 |
2008年 | 12篇 |
2007年 | 4篇 |
2006年 | 7篇 |
2005年 | 5篇 |
2004年 | 7篇 |
2003年 | 8篇 |
2002年 | 6篇 |
2001年 | 5篇 |
2000年 | 7篇 |
1999年 | 9篇 |
1998年 | 9篇 |
1997年 | 4篇 |
1996年 | 7篇 |
1994年 | 2篇 |
1992年 | 4篇 |
1991年 | 2篇 |
1990年 | 9篇 |
1989年 | 6篇 |
1988年 | 3篇 |
1986年 | 6篇 |
1985年 | 6篇 |
1984年 | 2篇 |
1982年 | 3篇 |
1981年 | 3篇 |
1980年 | 5篇 |
1978年 | 2篇 |
1974年 | 6篇 |
1972年 | 2篇 |
1970年 | 3篇 |
1969年 | 5篇 |
1968年 | 5篇 |
1967年 | 2篇 |
1965年 | 2篇 |
1964年 | 2篇 |
1963年 | 3篇 |
1956年 | 1篇 |
排序方式: 共有323条查询结果,搜索用时 15 毫秒
51.
52.
53.
54.
55.
Numerous studies have shown that long-chain polyunsaturated fatty acids can kill cancer cells in vitro as well as in vivo, while normal cells remain unaffected. Unfortunately, the cellular and molecular mechanisms responsible for this phenomenon are still poorly understood. The aim of this study was to investigate the potential chemopreventative/antiproliferative potential of docosahexaenoic acid (DHA) in an adenocarcinoma cell line (CaCo2 cells) and to evaluate the signalling pathways modulated by it. DHA (5-50 microM) significantly inhibited cell viability in a dose-dependent manner in CaCo2 cells, while the viability of normal colon cells (NCM460 cells) was not compromised. DHA also induced apoptosis in CaCo2 cells, as indicated by increases in caspase-3 activation and poly-ADP-ribose polymerase cleavage. Signalling proteins, which include extracellular signal-regulated kinase, p38 mitogen-activated protein kinase (MAPK), Akt and p53 were analysed by Western blotting using phosphospecific and total antibodies. The protein inhibitors wortmannin (phosphoinositide 3 kinase inhibitor), PD 98059 (MEK inhibitor) and SB 203580 (p38 inhibitor) as well as silencing RNA [small interfering RNA (siRNA)] of the p38 MAPK protein, were used to investigate cross-talk between signalling pathways. DHA supplementation significantly suppressed Akt phosphorylation, which also correlated with decreased cell viability and increased apoptosis in CaCo2 cells. Furthermore, siRNA experiments suggested a possible role for p38 MAPK in the phosphorylation of p53 at Ser15, a site which is associated with DNA damage. DHA might thus exert its beneficial effects by means of increased apoptosis and suppression of the important survival-related kinase, Akt. 相似文献
56.
Robert O. Hughes John K. Walker D. Joseph Rogier Steve E. Heasley Rhadika M. Blevis-Bal Alan G. Benson E. Jon Jacobsen Jerry W. Cubbage Yvette M. Fobian Dafydd R. Owen John N. Freskos John M. Molyneaux David L. Brown Brad A. Acker Todd M. Maddux Mike B. Tollefson Joseph B. Moon Brent V. Mischke Jeanne M. Rumsey Yi Zheng Ying Yu 《Bioorganic & medicinal chemistry letters》2009,19(17):5209-5213
We describe efforts to improve the pharmacokinetic profile of the aminopyridopyrazinone class of PDE5 inhibitors. These efforts led to the discovery of 3-[(trans-4-hydroxycyclohexyl)amino]-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido[3,4-b]pyrazin-2(1H)-one, a potent and selective inhibitor of PDE5 with an excellent PK profile. 相似文献
57.
Background
In the past decade, an enormous number of new bioprocesses have evolved in the biotechnology industry. These bioprocesses have to be developed fast and at a maximum productivity. Up to now, only few microbioreactors were developed to fulfill these demands and to facilitate sample processing. One predominant reaction platform is the shaken microtiter plate (MTP), which provides high-throughput at minimal expenses in time, money and work effort. By taking advantage of this simple and efficient microbioreactor array, a new online monitoring technique for biomass and fluorescence, called BioLector, has been recently developed. The combination of high-throughput and high information content makes the BioLector a very powerful tool in bioprocess development. Nevertheless, the scalabilty of results from the micro-scale to laboratory or even larger scales is very important for short development times. Therefore, engineering parameters regarding the reactor design and its operation conditions play an important role even on a micro-scale. In order to evaluate the scale-up from a microtiter plate scale (200 μL) to a stirred tank fermenter scale (1.4 L), two standard microbial expression systems, Escherichia coli and Hansenula polymorpha, were fermented in parallel at both scales and compared with regard to the biomass and protein formation. 相似文献58.
59.
J N Freskos J J McDonald B V Mischke P B Mullins H S Shieh R A Stegeman A M Stevens 《Bioorganic & medicinal chemistry letters》1999,9(13):1757-1760
We have discovered a new series of potent conformationally constrained MMP Inhibitors that are selective for MMP-13 over MMP-1. 相似文献
60.
Anton Shetnev Angelina Osipyan Sergey Baykov Alexander Sapegin Zhanna Chirkova Michail Korsakov Anél Petzer Idalet Engelbrecht Jacobus P. Petzer 《Bioorganic & medicinal chemistry letters》2019,29(1):40-46
Series of structurally diverse 2-imidazoline derivatives have been synthesized by condensation of substituted aldehydes with ethylenediamine, Pd-catalyzed N-arylation of 2-imidazolines and by the formation of 1,2,4-oxadiazoles and benzoxazepines from 2-imidazoline-containing precursors. The 2-imidazoline derivatives were evaluated as potential inhibitors of human monoamine oxidase (MAO) A and B. Among the 2-imidazolines, good potency inhibitors were discovered with compound 9p (IC50?=?0.012?µM) being the most potent MAO-B inhibitor, while compound 9d (IC50?=?0.751?µM) was the most potent MAO-A inhibitor of the series. These potencies are in the same range as those of reference MAO inhibitors used in the clinic. Among 33 compounds evaluated, 13 exhibited IC50 values in the submicromolar range for the inhibition of an MAO isoform. It is postulated that the imidazoline moieties of some of these inhibitors may be recognized by the imidazoline I2-binding site of MAO. Good potency MAO inhibitors may be useful for the treatment of neuropsychiatric and neurodegenerative disorders such as depression and Parkinson’s disease, and future application for the treatment of prostate cancer, congestive heart failure and Alzheimer’s disease. In addition, high potency 2-imidazoline-derived MAO inhibitors may be used as potential probes for the imidazoline binding sites of the MAOs, as well as to determine alternative binding regions of imidazoline within the MAO active site. 相似文献